Galderma Group AG (CHIX:GALDZ) Change In Payables And Accrued Expense : CHF0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Change In Payables And Accrued Expense?

Galderma Group AG's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was CHF0 Mil. It means Galderma Group AG's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Dec. 2024 .

Galderma Group AG's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was CHF0 Mil. It means Galderma Group AG's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Galderma Group AG Change In Payables And Accrued Expense Historical Data

The historical data trend for Galderma Group AG's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Change In Payables And Accrued Expense Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Change In Payables And Accrued Expense

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Change In Payables And Accrued Expense	-	-	-	-

Galderma Group AG Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0 Mil.

Galderma Group AG Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (CHIX:GALDz) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

GALDY:USA GDERF:USA PY3:Germany GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines